drugset / Trial / NCT01656382
Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if initial therapy with ABLC at 10/mg/kg/d for 7 days are at least effective as ABLC at 5.0 mg/kg/d X 14 days as induction treatment of patients with disseminated cryptococcosis and HIV.
Timeline
- Start
- 2007-01
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amphotericin B | Unknown | 5 mg/kg | — |
| Subject | Amphotericin B | Unknown | 10 mg/kg | — |